(August 14, 2015, 10:45 AM EDT) -- LOS ANGELES — A California federal judge presiding over a Cymbalta withdrawal trial on Aug. 13 issued a directed verdict during the third day of trial (Erin Hexum, et al. v. Eli Lilly and Company, No. 13-2701, C.D. Calif.).

A source told Mealey Publications that U.S. Judge Steven V. Wilson of the Central District of California issued a ruling that “meaningfully limited” the testimony of a plaintiff expert. The source said the prescribing physician’s testimony thereby barred plaintiff Erin Hexum’s claims.

T. Matthew Leckman of Pogust,...